News
Rocket crashes as gene therapy patient dies, FDA imposes hold
The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, which was aiming to report data in mid-2026, dropped its targeted trial completion date and outlined actions to extend its cash runway after suffering the setback.
1don MSN
That's the bad news. The good news is that Rocket Lab remains on a strong growth track. Once Neutron begins launching ...
Live updates from Saturday's SpaceX Starlink 12-22 mission that launched a Falcon 9 rocket from Cape Canaveral Space Force ...
Our countdown includes NASA and Blue Origin replicas as well as Estes models with cameras and STEM sets for kids.
Archer Aviation plans to deliver a lot more aircraft. Rocket Lab plans to launch more rockets. One of these companies has a ...
Johnston Atoll with its Hawaiian name Kalama is about 825 miles southwest of Hawaii in the Central Pacific. The ...
Epic Games' 2015 title Rocket League is nearing its 10th anniversary. The game, which fuses racecar driving with soccer, broke the esports mold with its unique ...
The Kinetica-1 rocket launched Wednesday for the first time since a failure doomed its previous attempt to reach orbit in ...
Activist ValueAct has a keen appreciation for artificial intelligence, and Rocket is poised to supercharge its business.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback